56 related articles for article (PubMed ID: 11882998)
1. The transmembrane protein of HIV-1 primary isolates modulates cell surface expression of their envelope glycoproteins.
Lebigot S; Roingeard P; Thibault G; Lemiale F; Verrier B; Barin F; Brand D
Virology; 2001 Nov; 290(1):136-42. PubMed ID: 11882998
[TBL] [Abstract][Full Text] [Related]
2. Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolates and their relationship to immunogenicity.
Brand D; Lemiale F; Thibault G; Verrier B; Lebigot S; Roingeard P; Buzelay L; Brunet S; Barin F
Virology; 2000 Jun; 271(2):350-62. PubMed ID: 10860888
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of a nonsyncytium inducer HIV-1 glycoprotein inhibits syncytium formation by another HIV-1 Env protein.
Li YY; O'Donnell MA; Perez LG
Virology; 1996 Jan; 215(2):197-202. PubMed ID: 8560767
[TBL] [Abstract][Full Text] [Related]
4. Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family.
Ohno H; Aguilar RC; Fournier MC; Hennecke S; Cosson P; Bonifacino JS
Virology; 1997 Nov; 238(2):305-15. PubMed ID: 9400603
[TBL] [Abstract][Full Text] [Related]
5. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage.
Pancera M; Wyatt R
Virology; 2005 Feb; 332(1):145-56. PubMed ID: 15661147
[TBL] [Abstract][Full Text] [Related]
6. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
7. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
Hernández M; Pozo L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
[TBL] [Abstract][Full Text] [Related]
8. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
Virology; 2006 Aug; 352(1):74-85. PubMed ID: 16725170
[TBL] [Abstract][Full Text] [Related]
9. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
Chan WE; Chen SS
Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1.
Jeffs SA; Goriup S; Kebble B; Crane D; Bolgiano B; Sattentau Q; Jones S; Holmes H
Vaccine; 2004 Feb; 22(8):1032-46. PubMed ID: 15161081
[TBL] [Abstract][Full Text] [Related]
12. An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.
Mische CC; Yuan W; Strack B; Craig S; Farzan M; Sodroski J
Virology; 2005 Jul; 338(1):133-43. PubMed ID: 15950253
[TBL] [Abstract][Full Text] [Related]
13. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
Day JR; Van Damme N; Guatelli JC
Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
15. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
[TBL] [Abstract][Full Text] [Related]
16. Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells.
Pfeiffer T; Pisch T; Devitt G; Holtkotte D; Bosch V
FEBS Lett; 2006 Jun; 580(15):3775-8. PubMed ID: 16777098
[TBL] [Abstract][Full Text] [Related]
17. The dominant-negative action of a fusion protein containing the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 in virus replication.
Chan WE; Chen SS
J Biomed Sci; 2007 Nov; 14(6):717-29. PubMed ID: 17610148
[TBL] [Abstract][Full Text] [Related]
18. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
Malinowsky K; Luksza J; Dittmar MT
Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
Molina L; Grimaldi M; Robert-Hebmann V; Espert L; Varbanov M; Devaux C; Granier C; Biard-Piechaczyk M
Proteomics; 2007 Sep; 7(17):3116-30. PubMed ID: 17676665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
